UNSPSC 51281500: Antitubercular drugs

This classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.

UNSPSC 51281500 Antitubercular drugs is a Class code, but the recent state and local opportunities tagged under it do not reflect antitubercular pharmaceuticals; instead, they show procurement of emergency response medications, generic multi-source pharmaceuticals through cooperative purchasing, and medical supply contracts. Seminole County, Florida is procuring naloxone and drug deactivation systems through an IFB (due Jul 26, 2023); the City of Tampa is seeking medical and first aid supplies for its fire department rescue division through an ITB with an estimated contract value of $700,000.00 and a response deadline of Mar 13, 2026; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is soliciting generic multi-source pharmaceuticals and OTC products through an RFP due Mar 26, 2026. The mismatch between the code's nominal scope and the work actually being solicited suggests the code sees little relevant recent activity aligned to antitubercular products specifically. Issuing bodies include county health departments, municipal fire services, and multistate cooperative purchasing organizations. The Code does not identify standout repeat buyers or a concentrated set of jurisdictions.

Geographic activity spans Florida (Seminole County), Florida (City of Tampa), Texas (Texas Health and Human Services Commission, posted Apr 3, 2026 for a pharmacy benefit RFI), and Minnesota (MMCAP, which serves participating state and local facilities across Minnesota and Oregon). The Tampa procurement carries a small local business enterprise (SLBE) set-aside with a 5 percent bid discount not to exceed $10,000.00; the MMCAP solicitation does not specify set-aside designations. The mismatch between the antitubercular code label and the actual procurement scope suggests this code may be incorrectly tagged in state and local systems or that recent opportunities have been classified under an inappropriate UNSPSC category; business development professionals should verify the correct code assignment before pursuing opportunities listed under 51281500.